Trials / Completed
CompletedNCT00189501
A Multi-Center, Observational Registry of Subjects With Secondary Hyperparathyroidism (HPT) and Chronic Kidney Disease (CKD)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,000 (planned)
- Sponsor
- Amgen · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Objectives include description of current practices; assessment over time of K/DOQI goals, clinical outcomes, health resource utilization(HRU) and patient reported outcomes (PRO) and the impact of Sensipar® on these parameters
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sensipar® |
Timeline
- Start date
- 2004-12-01
- First posted
- 2005-09-19
- Last updated
- 2007-12-28
Source: ClinicalTrials.gov record NCT00189501. Inclusion in this directory is not an endorsement.